Conditions: Overactive Bladder
Keywords: Double-blind Placebo-controlled frequency urgency web-based incontinence methodology ediary safety efficacy tolerability ER overactive bladder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 18
Healthy volunteers: no

Brief summary:
To compare the effect of tolterodine ER 4 mg to placebo on patient reported outcomes in subjects with overactive bladder after 1, 4, and 12 weeks of treatment using an innovative web-based trial design

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Tolterodine ER intervention 2: Placebo
Intervention descriptions: intervention 1: One 4 mg capsule will be taken with water every day with or without food. It should be swallowed whole without chewing. intervention 2: A placebo of Tolterodine ER 4 mg will be taken with water every day with or without food. It should be swallowed whole without chewing.

Protocol document: